Download your application note on TGF-β/SMAD/α-SMA signaling in NASH
Discover the benefits of using HTRF assays to characterize liver fibrosis.
Several molecular markers have been investigated as possible factors in the progression of non-alcoholic steatohepatitis (NASH) towards liver fibrosis.
The TGF-b/SMAD/α-SMA pathway has a crucial role in this progression and has emerged as an important therapeutic target.
This application note will allow you to:
Get an overview of the liver fibrosis mechanism’s function and dynamics
Take advantage of HTRF technology to study the TGF-β/SMAD/α-SMA signaling axis
Benefit from additional content to help you revolutionize NASH discovery
Get your application note
We are committed to your privacy. Revvity needs the contact information you provide us to keep you aware about relevant content, products, and services. You may unsubscribe from these communications at any time. For more information check out our Privacy Policy.
